The Pax-3 protein contains two DNA-binding domains, a paired domain and a homeodomain. Mutations in Pax-3 cause Waardenburg syndrome (WS) in humans and the mouse Splotch (Sp) phenotype. In the Sp-delayed mouse, a mutation in the Pax-3 paired domain (G9R) abrogates the DNA-binding activity of both the paired domain and the homeodomain, suggesting that they may functionally interact. To investigate this possibility further, we have analyzed the DNA-binding properties of additional point mutants in the Pax-3 paired domain and homeodomain that occur in WS patients (F12L, N14H, G15S, P17L, R23L, G48A, S51F and G66D in the paired domain, V47F and R53G in the homeodomain), the Pax-1 un mutation (G15A) and a substitution associated with Peters' anomaly in the PAX-6 gene (R23G). Within the paired domain, seven of 10 mutations were found to abrogate DNA-binding by the paired domain. Remarkably, these seven mutations also affected DNA binding by the homeodomain, causing either a complete loss (P17L and G66D), a reduction (R23G, R23L, G15S and G15A) or an increase in DNA-binding activity (N14H). In addition, the effect of paired domain mutations occurred at the level of monomer formation by the homeodomain, while the dimerization potential of this domain seemed unaffected in mutants where it could be analyzed. Furthermore, while both homeodomain mutations were found to abolish DNA binding by this domain, the R53G mutation also abrogated DNA binding by the paired domain. The important observation that independent mutations in either domain can affect DNA binding by the other in the intact Pax-3 protein strongly suggests that the two domains are not functionally independent but bind DNA through cooperative interactions. Modeling the deleterious mutations on the three-dimensional structure of the paired domain of Drosophila Prd shows that these mutations cluster at the DNA interface, thus suggesting that a series of DNA contacts are essential for DNA binding by both the paired domain and the homeodomain of Pax-3.
INTRODUCTION
Pax-3 is a member of the mammalian Pax gene family (1), a group of nine transcription factors that are structurally defined by the presence of a highly conserved 128 amino acid DNA-binding domain, known as the paired domain and initially identified in the paired segmentation gene of Drosophila (2) . In addition to the paired domain, certain members of the Pax family, including Pax-3, 4, 6 and 7, harbor a second DNA-binding domain, the paired-type homeodomain (1, 3) . For the most part, Pax genes are expressed in distinct spatial and temporal patterns during embryogenesis, in particular within the developing nervous system (1) . Over the past several years, the importance of Pax genes in regulating development has been established with the analysis of several mutations in both mice and humans (4) . In the mouse mutant undulated (un), a point mutation in the Pax-1 gene is responsible for the abnormal development of the vertebral column and sternum (5) . The human PAX-6 gene is mutated in aniridia (6) (7) (8) and the mouse Pax-6 gene is allelic with the Small-eye mutant (9) , with both displaying ocular disturbances and other brain and nasal abnormalities. Mutations in the Caenorhabditis elegans PAX-6 homologs vab-3 and mab-18 result in many defects in head-region and ray (simple sense organs) development respectively (10) (11) . PAX-2 heterozygous mutations result in eye and kidney abnormalities and sometimes hearing deficits. Homozygous Pax-2 knockout mice have renal agenesis as well as ocular and brain abnormalities (12) . In the case of Pax-3, loss-of-function mutations cause the Splotch (Sp) phenotype in mice (13) (14) (15) and Waardenburg syndrome (WS) in humans (16) , both of which are semi-dominant mutations expressed as pigmentary disturbances in the heterozygous state. In addition, WS characteristics include dystopia canthorum and sensorineuronal deafness (17) . Homozygous Sp embryos die in utero and display profound defects in neurogenesis, dysgenesis of *To whom correspondence should be addressed. Tel: +1 514 398 7291; Fax: +1 514 398 2603; Email: gros@medcor.mcgill.ca Proteins were resolved by SDS-PAGE (12.5%), transferred to nitrocellulose and Pax-3 was detected using a specific rabbit polyclonal antiserum (28) and chemiluminescence. The position of the protein standards (kDa) is shown to the left. Mock refers to whole cell extracts from untransfected COS-7 cells.
neural crest cell-derived structures as well as the absence of certain tissues derived from somitic mesoderm (18) (19) (20) (21) .
The high resolution three-dimensional structure of the paired domain-DNA complex has been elucidated for the paired (Prd) protein of Drosophila (22) . The paired domain is structurally divided into two subdomains, each containing three α-helices that form a classical helix-turn-helix (HTH) motif. In addition, the N-terminal subdomain contains a β-hairpin motif and a type II β-turn that, together with the HTH motif, make important contributions to DNA binding. Although all naturally occurring mammalian point mutations mapping to the paired domain are located within this N-terminal subdomain, recent studies of alternatively spliced isoforms of Pax-6 and Pax-3 suggest that the C-terminal subdomain also contributes to the DNA-binding specificity of the paired domain (23, 24) . The paired domain has been shown to bind DNA on its own and target oligonucleotides that are recognized preferentially by the N-terminal subdomain or by both the N-and C-terminal subdomains have been identified (22, 24, 25) . Like the paired domain, the paired-type homeodomain comprises three α-helices, the last two forming an HTH motif in which helix 3 makes extensive DNA contacts. Despite this similarity, the paired-type homeodomain has distinct sequence preferences and shows a unique ability to dimerize cooperatively on target sequences containing the palindromic TAAT-(N) 2/3 -ATTA motif (26) .
Although the ability of the paired domain and homeodomain to bind DNA with high affinity as modular units has been established using the isolated domains (25) (26) (27) , recent results suggest that these domains do not function independently within the intact molecule but interact cooperatively to select DNA targets in vivo. For example, a single glycine to arginine substitution in the paired domain of Pax-3 in the Sp d mouse mutant abrogates DNA binding by both the paired domain and the homeodomain (28) . Furthermore, rescue of a null mutation of Drosophila paired requires the presence of both DNA-binding domains in the same polypeptide in vivo (29) (30) (31) . In the present study, we wished to test this hypothesis further by taking advantage of a large number of loss-of-function mutations found in WS patients that are predicted to affect different structural components of the Pax-3 protein. The DNA-binding properties of these mutations were analyzed systematically, in particular with respect to possible pleiotropic effects of paired domain mutations on homeodomain DNA binding and vice versa. We have established that a large number of WS mutations in the paired domain abrogate its DNA-binding activity and, at the same time, have profound effects on homeodomain DNA binding. Likewise, a WS mutation in the Pax-3 homeodomain was found to abolish DNA binding by both domains. Finally, the position of these mutations within the paired domain crystal structure suggests that Human Molecular Genetics, 1997 , Vol. 6, No. 11 1783 a series of consecutive phosphate contacts are essential for DNA binding by both the paired domain and the homeodomain.
RESULTS

Mutations introduced in Pax-3
The goal of this study was to gain further insight into the structural and functional relationships within the Pax-3 protein. In particular, we wished to investigate possible functional interactions between the two DNA-binding domains of the protein, so we set out to determine to what extent alterations in the paired domain may affect homeodomain DNA binding and, conversely, if mutations in the homeodomain could alter paired domain function. To accomplish this, we investigated the DNA-binding properties of mutant alleles of human PAX-3 found in patients with WS type I (WSI) (16) that map within the paired domain (F12L, N14H, G15A, P17L, R23L, G48A, S51F and G66D) or homeodomain (V47F and R53G). In addition, the naturally occurring G15S mutation in the Pax-1 gene of the undulated (un) mouse mutant (32) and the R23G mutation found in the human PAX-6 gene associated with Peters' anomaly (8) were also studied in the context of the Pax-3 polypeptide.
The position of the mutations within the Pax-3 paired domain is shown in Figure 1A with respect to the secondary structural elements derived from the crystal structure of Drosophila Prd (22) . This portion of the paired domain is comprised of three components: a β-hairpin motif made up of two β-strands, a type II β-turn, and a helical domain that contains a classical HTH motif (Fig. 1A) . Each of these structures makes extensive phosphate contacts along the paired domain recognition sequence (summarized in Fig. 1A ). In addition, both the type II β-turn and the C-terminal tail of the N-terminal subdomain make specific contacts in the minor groove, while helix 3 engages the DNA in the major groove (summarized in Fig. 1A) . Importantly, the mutations analyzed in this study are expected to affect all of these structural features. The F12L mutation is located in the second β-strand of the β-hairpin motif, while N14H, G15A, G15S and P17L all affect the type II β-turn (Fig. 1A) . Four mutations map to the helical domain and involve the R23G and R23L substitutions in helix 1, and the G48A and S51F substitutions in helix 3 (Fig. 1A) . Lastly, the G66D mutation is located within the carboxy-terminal tail of the N-terminal subdomain (Fig. 1A) .
The wild-type and mutated Pax-3 variants were expressed by transient transfection in COS-7 cells, and whole cell extracts were prepared from transfectants and analyzed by immunoblotting for the presence of Pax-3 using a polyclonal anti-Pax-3 antibody (28) . As shown in Figure 1B , a single polypeptide of the expected M r (56 kDa) was detected by the antibody in each whole cell extract. In addition, it is clear that the recombinant Pax-3 proteins were expressed at similar levels. As a result, equal amounts of recombinant Pax-3 could be used in our initial analysis of paired domain and homeodomain DNA-binding properties.
DNA-binding properties of paired domain mutants
The DNA-binding properties of Pax-3 proteins containing mutations in the paired domain were analyzed by electrophoretic mobility shift assay (EMSA) using oligonucleotides specific for the paired domain: Nf3′ was selected for high affinity binding to the Pax-3 paired domain by the SELEX procedure (33) and H2A2.1 is a sequence found in the promoter of the sea urchin The DNA-binding properties of wild-type and mutant variants of Pax-3 were measured by electrophoretic mobility shift assay (EMSA), as described in Materials and Methods. The paired domain DNA-binding properties were monitored by EMSA using target oligonucleotides specific for the paired domain, H2A2.1 (25) and Nf3′ (33) (top two panels). The DNA-binding properties of the homeodomain were monitored by EMSA using either the homeodomainspecific oligonucleotide P2 (26) (third panel) or the half-site probe P1/2 (26) that allows quantitation of monomer binding by the homeodomain (fourth panel). The mutations tested are ordered from left to right with respect to their position in the paired domain (amino-to carboxy-terminus). Arrowheads to the right of each panel identify monomeric (M) and dimeric (D) Pax-3 complexes, as well as the free probe (F). For each panel, equivalent amounts of Pax-3 protein were introduced in the assay, while the various probes were labeled to similar specific activity, and the gels were exposed for comparable amounts of time.
H2A-2 histone gene that is bound by several Pax proteins, including Pax-3 (25) . Results shown in Figure 2 indicate that wild-type Pax-3 binds to both oligonucleotides with high specificity (lane 2 of the top two panels). Interestingly, the 10 paired domain mutations could be classified into two groups based on their effect on DNA binding by the paired domain. First, mutations N14H, G15A, G15S, P17L, R23G, R23L and G66D (Fig. 2 , lanes 4-9 and 12, top two panels) caused a complete loss of DNA binding to Nf3′ and H2A2.1, and this is in agreement with their loss-of-function phenotype in vivo. In contrast, the F12L, G48A and S51F substitutions did not appear to affect DNA binding by the paired domain to Nf3′ and H2A2.1 (compare lane 2 with lanes 3, 10 and 11), despite showing an identical loss-of-function phenotype in vivo. Moreover, similar DNA-binding characteristics were observed when (i) these mutants were analyzed using additional oligonucleotides specific for the paired domain [P6CON(34), CD19-2/A (25), PRS-4 (35) and e5 (36) ] and (ii) when serial dilution of individual protein were used (data not shown). It appears, therefore, that the underlying cause of WS in these three patients may not be related to a loss of DNA binding by the paired domain.
Our previous analysis of the mouse Sp d mutant had indicated that a mutation in the Pax-3 paired domain (G9R) could affect DNA binding by the homeodomain, and we therefore investigated this possibility in the series of paired domain mutants described in Figure 1 . For this, EMSAs were carried out using an oligonucleotide (P2) that contains the core recognition motif 5′TAATTGATTA3′ and which promotes dimerization by paired-type homeodomains (26) , including the Pax-3 homeodomain (28) . As expected, wild-type Pax-3 binds to this oligonucleotide with high affinity, forming both the monomeric and dimeric complexes (Fig. 2 , lane 2, third panel). Upon analysis of the paired domain mutants, several interesting phenotypes were observed that ranged from a complete loss of homeodomain DNA-binding activity to a notable increase in complex formation. Specifically, both the P17L and G66D mutations were found to abrogate DNA binding by the homeodomain (Fig. 2 , lanes 7 and 12, third panel), while the R23G and R23L substitutions caused a severe reduction in P2 binding (Fig. 2 , lanes 8 and 9, third panel). In addition, although the G15S and G15A substitutions retained the ability to form the slower migrating dimeric complex, there is an apparent reduction in the quantity of the monomeric complex formed with the P2 oligonucleotide ( The effects of paired domain mutations on the DNA-binding properties of the homeodomain were also examined using an oligonucleotide (P1/2) which contains a single TAAT motif. This oligonucleotide does not sustain dimer formation and therefore allows us to examine any effect of these mutations on monomeric binding by the Pax-3 homeodomain (Fig. 2 , bottom panel) that may have been masked by dimerization on the P2 oligonucleotide. Consistent with their binding to Nf3′, H2A2.1 and P2, the F12L, G48A and S51F mutations also retained DNA-binding activities similar to wild-type Pax-3 when analyzed using the P1/2 oligonucleotide (Fig. 2 , compare lane 2 with lanes 3, 10 and 11, lower panel). Similarly, the R23G, R23L, P17L and G66D mutations, which exhibited either a complete loss or severe reduction in binding to the P2 oligonucleotide, abrogated binding to the P1/2 oligonucleotide (Fig. 2, lanes 7-9 and 12, lower panel) . Interestingly, the reduction in monomeric binding by the G15A and G15S mutants on the P2 oligonucleotide is associated with a complete loss of binding by these mutants to the P1/2 oligonucleotide (Fig. 2, lanes 5 and 6, lower panel) . This would suggest that the effect of paired domain mutations at position 15 are at the level of monomeric binding by the Pax-3 homeodomain. Likewise, the increase in DNA binding by the N14H mutant to the P2 oligonucleotide is paralleled by a similar increase in monomer formation on P1/2 (Fig. 2, lane 4, lower panel) . Summarizing the analysis thus far, the seven mutations that abrogate DNA binding by the paired domain were all found to have an effect on the monomeric DNA-binding properties of the Pax-3 homeodomain and this clearly establishes an important role for the paired domain in homeodomain DNA binding.
The unique effects of the G15A, G15S and N14H mutations on the DNA-binding properties of the homeodomain were also investigated in a more quantitative fashion. In this case, EMSAs were performed using the P2 and P1/2 oligonucleotides with four serial 2-fold dilutions of whole cell extracts containing these mutants or wild-type Pax-3 ( Fig. 3) . At high protein concentrations, the intensity of the complexes formed by the G15A and G15S mutants and P2 was quantitatively similar to that seen with wild-type Pax-3 (Fig. 3A, lanes 1 and 2) . However, at lower protein concentrations, wild-type Pax-3 binds predominantly as a monomer to the P2 oligonucleotide (Fig. 3A, WT, lane 3) , while only the dimeric complex is observed with the G15A and G15S proteins (Fig. 3A, G15A and G15S, lane 3) . The extent to which the G15A and G15S mutations reduce monomeric binding by the Pax-3 homeodomain was most apparent when the P1/2 oligonucleotide was used, as no binding could be detected for either mutant at all protein concentrations tested, even after prolonged exposure of the gel (Fig. 3A, right panels) . A similar analysis verified the opposite effect of the N14H mutation on homeodomain binding (Fig. 3B) . At all protein concentrations tested, we observed increased binding of this mutant to the P2 oligonucleotide when compared with wild-type Pax-3 (Fig. 3, left  panels) . Furthermore, this increase in P2-binding activity was concomitant with an 8-to 10-fold increase in monomeric binding to the P1/2 oligonucleotide (Fig. 3B, right panels) . Consequently, mutations in the paired domain with distinct effects on DNA binding by the Pax-3 homeodomain affect monomeric binding by the homeodomain and establish a role for the paired domain in this process. The systematic analysis of these mutations provides definitive evidence for an important functional interaction between the paired domain and the homeodomain of Pax-3.
DNA-binding properties of homeodomain mutants
The homeodomain found in Drosophila Prd and the mammalian Pax proteins defines a distinct sub-class which includes the Phox1 and S8 proteins (37) . Crystal structures solved for the homeodomains of the Drosophila engrailed (38) and Prd (39) proteins reveal a common tertiary structure that is composed of three α-helices, the last two of which form an HTH motif. The most conserved segment of the 300 homeodomains known to date is helix 3, which makes extensive DNA contacts in the major groove and is important for sequence specificity of individual homeodomain (40) . The remaining DNA contacts are made by a flexible N-terminal arm that contacts the DNA-phosphate backbone and minor groove (39) . Notably, the two known WSI mutations in the homeodomain are located in helix 3 at positions 47 [NIH3 (V47F); 41] and 53 [NIH8 (R53G); 41] (Fig. 4A) . Their relative orientation with respect to each other and to the DNA is summarized in Figure 4B . Both residues are situated within the DNA major groove and make several phosphate and base-specific contacts that are important for docking of the homeodomain on DNA.
The analysis described above had indicated that several paired domain mutations affected the DNA-binding properties of the homeodomain. We were therefore interested in determining whether mutations in the homeodomain would affect DNA binding by the paired domain, reinforcing the notion of a functional interaction between the two domains. Consequently, the V47F and R53G mutations were introduced into the murine Pax-3 cDNA and expressed in COS-7 cells by transient transfection.
Immunoblotting analysis of whole cell extracts corresponding to the V47F and R53G polypeptides indicated that neither mutation affected protein stability and that similar amounts of Pax-3 protein were present in each extract (Fig. 4C) . Subsequently, the DNA-binding properties of these mutants were tested by EMSA using the Nf3′, H2A2.1, P2 and P1/2 oligonucleotides (Fig. 4D) . Both the V47F and R53G mutations were found to abrogate DNA binding to the P2 and P1/2 probes (Fig. 4D) , and this is consistent with the important role of these residues in the interaction of the homeodomain with DNA. Interestingly, of the two mutations, one also affected the paired domain DNA-binding properties. For both paired domain-specific oligonucleotide probes tested (Nf3′ and H2A2.1), the V47F mutant retained paired domain-specific DNA binding at levels similar to wild-type Pax-3, while on the contrary the R53G mutation eliminated paired domain binding to the two probes (Fig. 4D) . Taken together, these results indicate that a mutation that causes a loss of DNA binding by the homeodomain alone (in V47F) is sufficient to cause loss of function in vivo, consistent with the notion that both DNA-binding domains are essential for Pax-3 function in vivo. Furthermore, the loss of paired domain binding observed in the homeodomain mutant R53G indicates that a mutation in the homeodomain can influence DNA binding by the paired domain. The reciprocal loss of DNA binding by either the paired domain or the homeodomain caused by mutations in the other domain establish that neither domain functions as an independent modular unit in the intact protein. Our data are consistent with a model in which both domains are functionally interdependent and cooperate to achieve DNA-binding specificity in vivo.
DISCUSSION
Pax-3 is a member of the Pax family of transcription factors (1) which is structurally defined by the presence of a 128 amino acid residue DNA-binding domain, the paired domain (2). Pax-3 also contains a DNA-binding homeodomain, and transcription activation and repression domains (35) . Although the functional consequence of having two DNA-binding domains with distinct sequence specificity in Pax-3 and other Pax proteins is becoming clearer, it remains to be determined whether each domain retains its individual sequence specificity in the intact protein, or if cooperative interactions between the two domains define novel substrate specificities. The essential role of the paired domain and homeodomain for Pax-3 function has been established by the identification of mutations in these segments in human WSI patients and in the mouse neural tube defect mutant Splotch (13) (14) (15) . Indeed, the similarity in phenotypic expression of independent point mutations or deletions in either the paired domain or homeodomain of Pax-3 in unrelated WSI patients and in distinct Splotch alleles indicates that these mutations cause a complete loss of function. However, the molecular basis of the apparent loss of function in WSI alleles of Pax-3 has not been studied systematically. In the present study, we have introduced in Pax-3 a series of paired and homeodomain WSI mutations as well as other naturally occurring mutations in PAX-6 (8) and Pax-1 (32) , and have tested the functional consequence of these mutations on the DNA-binding properties of the paired domain and homeodomain of Pax-3.
The paired domain and homeodomain bind DNA with high affinity and specificity when expressed separately, and this has allowed the determination of their respective crystal structures complexed to cognate binding sequences (22, 39) . Although the paired domain comprises two globular subdomains, N-terminal and C-terminal, all WSI mutations affecting the paired domain are located in the N-terminal subdomain. This subdomain is made up of a β-hairpin structure that clamps the phosphate backbone, a type II β-turn that sits in the DNA minor groove, an HTH motif that lies in the major groove and a C-terminal tail that makes additional contacts in the minor groove. In the present study, the F12L, G48A and S51F mutations had no obvious effect on DNA binding, despite being located at the protein-DNA interface. The F12L mutation occurs in the β-hairpin structure and may disrupt a hydrophobic contact. However, this substitution is not predicted to affect the local secondary structure and suggests that the conservation of this structure may be more important than the DNA contact made by Phe12. This notion is consistent with a second mutation within the β-hairpin (Q7A) that preserves the local secondary structure and DNA-binding activity of the paired domain, despite the loss of a phosphate contact (42) . Although the G48A mutation has been proposed to cause a disruption of Van der Waal's contacts and possibly affect docking of the HTH motif (22) , its wild-type DNA-binding activity would suggest either that substitution with alanine does not affect these interactions or that they are not essential for paired domain DNA binding. This also appears to be the case with the S51F mutation which occurs adjacent to G48A in the HTH motif and indicates that the hydrophobic contact made by Ser51 may not be required for DNA binding. This raises the question as to what is responsible for the appearance of WS in these patients? First, a possible DNA-binding defect may be present in these mutants but may have gone undetected in our assay either because it is very subtle or our target oligos do not represent sequences normally bound by Pax-3 in vivo and may not be recognized by the mutants. Relevant to this argument, the S51F mutation was identified initially in a rare WS patient homozygous for the mutation (43), suggesting only a partial loss of function in this allele. In addition, the mutations may confer novel sequence specificities, a situation that has been described previously for the un mutation in Pax-1 (32) . These mutations may also affect homotypic or heterotypic interactions of Pax-3 with other proteins that may be important for proper target site selection by Pax-3 or for assembly of a functional transcriptional complex. It should also be noted that the penetrance of both WS and Sp mutations is affected by modifier loci and that these could act to increase the severity of the F12L, G48A and S51F mutations in these WS patients (44) .
Our study of paired domain mutations revealed that a large proportion (7/10) caused a complete loss of DNA binding by the paired domain and provides a molecular basis for the loss-of-function phenotype observed in these WSI and Peter's anomaly patients. Four of these mutations, N14H, G15A, G15S and P17L, affect conserved residues in the type II β-turn that lies in the DNA minor groove and clearly underline the importance of this structure in paired domain DNA binding. At position 15, glycine is the only residue that would allow the β-turn to approach the minor groove, and substitutions here would most likely affect other contacts made by the β-turn (22); our analysis is therefore consistent with the loss of paired domain DNA binding attributed to this mutation in the Pax-1 protein (32). Likewise, substitution of Asn14 and Pro17 would affect hydrogen bonding and interactions with the DNA backbone that are necessary to place the β-turn in the minor groove, and this would account for their effect on DNA binding. Immediately following the β-turn, helix 1 Arg23 makes a phosphate contact that helps anchor the HTH motif and may contribute to stabilizing the β-turn in the minor groove. Given that this residue also participates in hydrogen bonding with residues in the C-terminal tail of the N-terminal subdomain, it is understandable why the presence of leucine or alanine at this position would abrogate DNA binding by the paired domain. Parallel studies of the PAX-6 protein indicate that a mutation at this glycine residue (R26G) severely diminishes DNA binding to certain paired domain target sites such as CD19-2A (45) . Lastly, Gly66 is located in the C-terminal tail and interacts with the DNA backbone in a region that is adjacent to that contacted by the β-hairpin and the β-turn. The substitution by aspartate would most likely lead to electrostatic repulsion that reduces DNA binding of the N-terminal subdomain. Therefore, this analysis emphasizes the critical role of multiple paired domain structural elements in stabilizing the interaction of the paired domain with its DNA target.
Like the paired domain, the homeodomain also comprises three α-helices that contribute to an HTH motif (38, 39) , and binding of the homeodomain to DNA is mediated principally by helix 3, which sits in the major groove, and by a flexible N-terminal arm that makes phosphate and minor groove contacts (Fig. 4A) . The loss of homeodomain DNA binding activity attributed to the V47F and R53G WSI mutations indicates the requirement for this domain for Pax-3 function and is consistent with the fact that both mutations affect residues within helix 3 that participate directly in docking of the homeodomain on DNA. The arginine at position 53 represents one of the most highly conserved residues in the homeodomain superfamily, playing a general role in homeodomain DNA binding through the establishment of two phosphate contacts ( Fig. 4B;  39,40) . In addition to disrupting these contacts, the glycine substitution may also destabilize the α-helix and could, therefore, affect DNA contacts made by other residues within helix 3. In contrast, position 47 is more variable and is involved in conferring sequence specificity to a given homeodomain (40) . Homeodomains of the paired-class contain a valine at this position, and this residue makes a hydrophobic contact with the core TAAT motif in the homeodomain crystal structure of Drosophila paired (Fig. 4B, 39 ). Our analysis would therefore indicate that this contact is essential to DNA binding by the Pax-3 homeodomain.
The intriguing result of our analysis was that the seven WSI mutations that abrogated DNA binding by the paired domain had a profound effect on homeodomain DNA binding. Indeed, several paired domain mutations abolished DNA binding by both the paired domain and the homeodomain (P17L and G66D); although this loss of function at both sites could be explained by a non-specific effect of the paired domain mutations on overall structure and folding of Pax-3, the analysis of additional mutations suggested that this was not the case. We observed that certain paired domain mutations that abrogate DNA binding by the paired domain could either decrease (G15S, G15A, R23G and R23L) or increase (N14H) DNA binding by the homeodomain. This suggests that the paired domain may play an important role in regulating the DNA-binding properties of the homeodomain. Moreover, using oligonucleotides that distinguish between monomeric (P1/2) and dimeric (P2) binding by the Pax-3 homeodomain, it is clear that the deleterious effect of paired domain mutations occurs at the level of monomer binding by the homeodomain and that dimerization appears unaffected. The most striking example is provided by substitutions of Gly15 where robust dimer formation on P2 is observed, yet no binding to P1/2 can be detected (Figs 2 and 3A) . In addition, the overall increase in binding to the P2 oligonucleotide observed with the N14H mutation could be accounted for by a commensurate Figure 5 . Paired domain mutations altering DNA binding by both domains cluster to the phosphate backbone and minor groove. Contact map for the paired domain residues analyzed in this study. The paired domain DNA contacts are derived from those defined in the high resolution three-dimensional structure of the Drosophila Prd protein and include hydrophobic, Van der Waal's, hydrogen bonding, and electrostatic interactions (22) . Phosphates are indicated by circles, ribose rings by pentagons, base pairs by boxes between the complementary DNA strands, and water molecules by a circled W. Arrows are used to indicate contacts between the DNA and polypeptide. Amino acids in the Pax-3 paired domain that affect DNA binding by both domains are shown as filled boxes, while residues which had no impact on DNA binding by either domain are in open boxes. This diagram also includes two contacts made by the polypeptide backbone (MC7 and MC66), although the role of the MC7 (oval) contact could not be assessed by mutagenesis. In a separate analysis, mutations of Asn6, Leu8, Glu7 and Gly10 were found to impair function of the β-hairpin motif and would affect the four contacts made by this structure (filled) (42) . In addition, mutation of Asn14, Gly15, and Pro17 would affect the three minor groove contacts and a backbone contact (filled). Lastly, substitution of Arg23 and Gly66 would prevent the two phosphate contacts indicated (filled). The putative location of an additional phosphate contact that may accompany the N14H mutation is indicated and was determined using the InsightII software package from Biosym.
increase in monomeric binding to the P1/2 oligonucleotide. Together, these results show that the paired domain can regulate monomeric DNA binding of the homeodomain but does not seem to interfere with the dimerization property of the domain, suggesting that paired domain-homeodomain functional interaction is mechanistically independent of the dimerization processes. Normal dimerization on P2 in the apparent absence of monomeric DNA binding could be accounted for by a rapid dissociation of the mutants on the P2 probe induced by the paired domain mutations that may be overcome by stabilization of the complex upon homeodomain dimerization. Finally, the fact that the R53G mutation in the homeodomain was able to abrogate DNA binding by the paired domain suggests that the homeodomain influences paired domain binding in the intact Pax-3 protein. This reciprocal functional relationship needs to be verified in additional homeodomain mutants. Positioning the residues that, when mutated, affect DNA binding by both the paired domain and homeodomain onto the paired domain-DNA three-dimensional structure revealed that their distribution was not random (Fig. 5) . Rather, residues 14 (N14H), 15 (G15A-S), 17 (P17L), 23 (R23G-L) and 66 (G66D) contact the phosphate backbone and minor groove over three consecutive base pairs (Fig. 5 ). In addition, we have observed recently that alanine substitutions at positions 6, 8, 9 and 10, which form part of the N-terminal β-hairpin that contacts adjacent phosphates on the same DNA strand, also affect DNA binding by both domains in a manner similar to that described here (42) . This spatial relationship suggests that this clustered series of phosphate and minor groove contacts is absolutely essential for binding of the paired domain and homeodomain to DNA.
Taking this model into account, it is tempting to speculate that the N14H mutant may provide an additional phosphate contact that leads to an increased monomeric DNA binding by the Pax-3 homeodomain. In fact, modeling this substitution into the paired domain crystal structure (22) suggests that the positively charged histidine residue would be in a favorable context to interact with the negatively charged DNA-phosphate backbone (Fig. 5) . This unique DNA-binding behavior may be associated with the distinct phenotype of the affected members of the family carrying this mutation (WSIII) (46) . The recent analysis of the Drosophila even-skipped promoter identified a composite binding element that requires both the paired domain and the homeodomain of the Prd protein to function (30, 48) . In addition, similar sequences were identified by in vitro selection of optimal binding sites for a Prd polypeptide containing both domains, indicating that the paired domain and the homeodomain can cooperate in sequence recognition (31) . These findings support a model in which the paired domain binds adjacent to the homeodomain on a composite sequence. Our analyses are in agreement with such a model and suggest that the Pax-3 paired domain binds adjacent to the homeodomain even in the absence of a canonical paired domain recognition motif.
Taken together, our studies of naturally occurring Pax-3 mutations found in WSI patients have uncovered a clear interdependence between the two DNA-binding domains of Pax-3. Indeed, the reciprocal effect of paired domain and homeodomain mutations on the DNA-binding activity of each domain noted here points to a cooperative interaction between these two structures that is likely to be important for the selection of DNA targets by Pax-3 in vivo.
MATERIALS AND METHODS
Site-directed mutagenesis
A construct containing a portion of the Pax-3 cDNA (positions 297-1801) in the eukaryotic expression vector pMT2 has been described previously (28) . The pMT2Pax-3 construct encodes the full-length, 479 amino acid Pax-3 polypeptide. For mutagenesis, a 1.3 kb PstI Pax-3 restriction fragment that encodes the paired domain and the homeodomain was excised from pMT2Pax-3 and inserted into the corresponding site of the filamentous phage plasmid vector M13mp19 to make M13mp19Pax-3. The PstI restriction fragment is derived from a pMT2-based PstI site located 5′ of the Pax-3 AUG and a second site within the Pax-3 cDNA at position 1581. Single-stranded DNA was prepared from M13mp19Pax-3 after infection of Escherichia coli TG-1 cells and was used as a template for site-directed mutagenesis using a commercially available kit (Amersham, Arlington Heights, IL). Several independent mutations were introduced in the Pax-3 cDNA using the mutagenic oligonucleotides shown in Table 1 .
The presence of the desired mutation and the integrity of the mutagenized Pax-3 cDNA cassette were verified by dideoxy nucleotide sequencing (51) . Subsequently, Pax-3 cDNA segments containing mutations in the paired domain were excised from M13mp19Pax-3 as a SmaI fragment (Pax-3; pst 342-672), while fragments containing homeodomain mutations were released with KpnI (Pax-3, pst 563-1500) and then inserted into the homologous sites of the pMT2Pax-3 expression construct.
Expression and detection of Pax-3 in COS-7 cells
Pax-3 was expressed in COS-7 cells by transient transfection. Briefly, 10 6 COS-7 cells were grown in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum and transfected by CaPO 4 co-precipitation using 15 µg of supercoiled plasmid DNA prepared by CsCl density centrifugation. Transfections proceeded for 5 h, at which time the cells were treated for 1 min with HBS (0.14 M NaCl, 5 mM KCl, 0.75 mM Na 2 HPO 4 .2H 2 O, 6 mM dextrose, 25 mM HEPES, pH 7.05) containing 15% glycerol before placing in complete DMEM. Whole cell extracts were prepared 24 h later by sonication in a buffer containing 20 mM HEPES (pH 7.6), 0.15 M NaCl, 0.5 mM dithiothreitol (DTT), 0.2 mM EDTA, 0.2 mM EGTA and protease inhibitors [aprotinin, pepstatin, phenylmethylsulfonyl fluoride (PMSF) and leupeptin at 1µg/ml) and stored frozen at -80_C until use. The level of Pax-3 protein expression in these whole cell extracts was monitored by immunoblotting using a rabbit anti-Pax-3 polyclonal antiserum (28) at a 1:5000 dilution and was visualized by enhanced chemiluminescence using an anti-rabbit antibody coupled to horseradish peroxidase (Amersham). Autoradiograms were scanned for quantitation, and the level of Pax-3 expression was normalized for subsequent DNA-binding studies. Mock transfections refers to cells exposed to transfection buffer devoid of DNA.
Electrophoretic mobility shift assays (EMSA)
The DNA-binding properties of wild-type and mutant Pax-3 were analyzed by EMSA, according to a protocol we have previously described (28) . The DNA-binding properties of the paired domain and the homeodomain were analyzed using the oligonucleotides listed in Table 2 . Double-stranded oligonucleotides with 3′ recessed ends were end labeled with [α-32 P]dATP (3000 Ci/mmol, New England Nuclear) using the Klenow fragment of DNA polymerase I. Whole cell extracts were added to 5 fmol of radiolabeled oligonucleotide in a 20 µl volume containing 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM DTT, 2 mM MgCl 2 , 1 mM EDTA and 5% glycerol. To prevent non-specific binding, 1 µg of poly(dIdC)·poly(dI-dC) was included when using the Nf3′ and H2A2.1 oligonucleotides, while 2 µg of salmon sperm DNA was added when the P2 and P1/2 oligonucleotides were used. After a 30 min incubation at 20_C, samples were electrophoresed at 12 V/cm in 5% acrylamide:bis-acrylamide (29:1) gels containing 0.5× TBE (1× TBE is 0.18 M Tris-HCl, 0.18 M boric acid, 4 mM EDTA, pH 8.3). Gels were dried and exposed to a phosphor imaging plate for quantitation with a Fuji BAS 2000 phosphorimaging station and then to Kodak XAR film.
